Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rosacea | 8 | 2024 | 59 | 5.910 |
Why?
|
Skin Diseases | 6 | 2022 | 1094 | 2.370 |
Why?
|
Dermatology | 6 | 2023 | 918 | 1.680 |
Why?
|
Hidradenitis Suppurativa | 3 | 2022 | 178 | 1.380 |
Why?
|
Skin Care | 2 | 2022 | 57 | 0.990 |
Why?
|
Dermatitis, Atopic | 3 | 2022 | 731 | 0.980 |
Why?
|
Psoriasis | 3 | 2022 | 950 | 0.940 |
Why?
|
Epigenesis, Genetic | 4 | 2022 | 3802 | 0.870 |
Why?
|
Pyoderma Gangrenosum | 1 | 2024 | 84 | 0.850 |
Why?
|
Ostomy | 1 | 2021 | 33 | 0.770 |
Why?
|
Surgical Stomas | 1 | 2021 | 42 | 0.760 |
Why?
|
Skin | 7 | 2022 | 4484 | 0.720 |
Why?
|
Granuloma Annulare | 1 | 2019 | 29 | 0.660 |
Why?
|
Masseter Muscle | 1 | 2019 | 38 | 0.660 |
Why?
|
Consumer Health Information | 1 | 2021 | 215 | 0.650 |
Why?
|
Dermatologic Agents | 2 | 2024 | 313 | 0.640 |
Why?
|
Dicarboxylic Acids | 1 | 2018 | 77 | 0.610 |
Why?
|
Hair Removal | 1 | 2018 | 40 | 0.590 |
Why?
|
Eyebrows | 1 | 2018 | 37 | 0.590 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2022 | 2422 | 0.580 |
Why?
|
Nonprescription Drugs | 1 | 2018 | 118 | 0.570 |
Why?
|
Neuromuscular Agents | 1 | 2019 | 147 | 0.570 |
Why?
|
Hypertrophy | 1 | 2019 | 561 | 0.560 |
Why?
|
Metronidazole | 1 | 2018 | 232 | 0.560 |
Why?
|
Herpes Zoster | 1 | 2019 | 253 | 0.560 |
Why?
|
Aminoquinolines | 1 | 2016 | 107 | 0.540 |
Why?
|
Acne Vulgaris | 4 | 2024 | 358 | 0.540 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2018 | 212 | 0.520 |
Why?
|
Facial Neoplasms | 1 | 2016 | 125 | 0.510 |
Why?
|
Botulinum Toxins, Type A | 1 | 2019 | 237 | 0.500 |
Why?
|
Lasers, Gas | 1 | 2016 | 101 | 0.500 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2016 | 245 | 0.460 |
Why?
|
DNA Methylation | 4 | 2022 | 4398 | 0.450 |
Why?
|
Telemedicine | 3 | 2021 | 3051 | 0.440 |
Why?
|
Petrolatum | 1 | 2012 | 7 | 0.430 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2018 | 774 | 0.420 |
Why?
|
Self Care | 1 | 2018 | 796 | 0.420 |
Why?
|
Gastrointestinal Diseases | 1 | 2021 | 1200 | 0.420 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2016 | 592 | 0.410 |
Why?
|
Isotretinoin | 2 | 2024 | 134 | 0.400 |
Why?
|
Skin Neoplasms | 3 | 2022 | 5821 | 0.390 |
Why?
|
Urticaria | 1 | 2012 | 150 | 0.370 |
Why?
|
Prescription Drugs | 1 | 2018 | 631 | 0.370 |
Why?
|
Anti-Infective Agents | 1 | 2018 | 983 | 0.370 |
Why?
|
Cost of Illness | 1 | 2020 | 1936 | 0.360 |
Why?
|
Telomere-Binding Proteins | 1 | 2010 | 119 | 0.340 |
Why?
|
Colitis, Ulcerative | 1 | 2022 | 1922 | 0.340 |
Why?
|
Cosmetic Techniques | 2 | 2023 | 149 | 0.330 |
Why?
|
Crohn Disease | 1 | 2022 | 2279 | 0.330 |
Why?
|
Health Personnel | 1 | 2022 | 3335 | 0.310 |
Why?
|
Venous Thromboembolism | 1 | 2021 | 1866 | 0.300 |
Why?
|
Water | 1 | 2012 | 1411 | 0.260 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2010 | 612 | 0.260 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3084 | 0.260 |
Why?
|
Humans | 40 | 2024 | 761504 | 0.250 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3204 | 0.250 |
Why?
|
Telomere | 1 | 2010 | 943 | 0.230 |
Why?
|
Pandemics | 2 | 2020 | 8654 | 0.220 |
Why?
|
Aspartate Aminotransferases | 1 | 2024 | 416 | 0.210 |
Why?
|
Sebum | 1 | 2021 | 17 | 0.200 |
Why?
|
Erythema | 1 | 2023 | 262 | 0.190 |
Why?
|
Alanine Transaminase | 1 | 2024 | 603 | 0.190 |
Why?
|
DNA Repair | 1 | 2010 | 2045 | 0.190 |
Why?
|
Inflammation | 1 | 2021 | 10773 | 0.190 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2010 | 1841 | 0.190 |
Why?
|
Biomedical Research | 1 | 2016 | 3429 | 0.180 |
Why?
|
Research Design | 1 | 2016 | 6180 | 0.180 |
Why?
|
Lasers, Dye | 1 | 2020 | 28 | 0.180 |
Why?
|
Ecchymosis | 1 | 2020 | 32 | 0.180 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2872 | 0.180 |
Why?
|
Case-Control Studies | 3 | 2021 | 22176 | 0.160 |
Why?
|
Cicatrix, Hypertrophic | 1 | 2020 | 81 | 0.160 |
Why?
|
Pigmentation Disorders | 1 | 2019 | 105 | 0.160 |
Why?
|
Edema | 1 | 2023 | 766 | 0.160 |
Why?
|
Melanosis | 1 | 2019 | 93 | 0.160 |
Why?
|
E1A-Associated p300 Protein | 1 | 2019 | 123 | 0.160 |
Why?
|
Treatment Outcome | 7 | 2024 | 64680 | 0.150 |
Why?
|
Retrospective Studies | 6 | 2024 | 80636 | 0.150 |
Why?
|
Injections, Intramuscular | 1 | 2019 | 554 | 0.150 |
Why?
|
Lasers, Solid-State | 1 | 2019 | 176 | 0.140 |
Why?
|
Mastocytosis | 1 | 2019 | 150 | 0.140 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2019 | 259 | 0.140 |
Why?
|
Models, Organizational | 1 | 2020 | 546 | 0.140 |
Why?
|
Comorbidity | 2 | 2021 | 10508 | 0.140 |
Why?
|
Genes, cdc | 1 | 2007 | 114 | 0.140 |
Why?
|
Face | 2 | 2021 | 1026 | 0.140 |
Why?
|
Diagnostic Self Evaluation | 1 | 2018 | 224 | 0.140 |
Why?
|
Histones | 2 | 2021 | 2580 | 0.130 |
Why?
|
Receptors, Retinoic Acid | 1 | 2007 | 224 | 0.130 |
Why?
|
Chronic Disease | 2 | 2022 | 9318 | 0.130 |
Why?
|
Dermatitis | 1 | 2017 | 202 | 0.130 |
Why?
|
Hair | 1 | 2018 | 498 | 0.120 |
Why?
|
Glomerulonephritis, Membranoproliferative | 1 | 2013 | 40 | 0.110 |
Why?
|
Immediate-Early Proteins | 1 | 2007 | 449 | 0.110 |
Why?
|
Communicable Disease Control | 1 | 2020 | 846 | 0.110 |
Why?
|
Tretinoin | 1 | 2007 | 519 | 0.110 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 13639 | 0.110 |
Why?
|
Lasers | 1 | 2018 | 952 | 0.110 |
Why?
|
Cryoglobulinemia | 1 | 2013 | 84 | 0.110 |
Why?
|
Infection Control | 1 | 2020 | 981 | 0.100 |
Why?
|
Laser Therapy | 1 | 2019 | 1092 | 0.100 |
Why?
|
Histamine H1 Antagonists | 1 | 2012 | 100 | 0.100 |
Why?
|
Internship and Residency | 2 | 2023 | 5880 | 0.100 |
Why?
|
Microscopy | 1 | 2016 | 903 | 0.090 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2022 | 4352 | 0.090 |
Why?
|
Cell Separation | 1 | 2016 | 1720 | 0.090 |
Why?
|
Replication Protein A | 1 | 2010 | 53 | 0.090 |
Why?
|
Aged | 5 | 2024 | 169289 | 0.090 |
Why?
|
Melanoma | 2 | 2019 | 5709 | 0.080 |
Why?
|
Evidence-Based Medicine | 1 | 2021 | 3688 | 0.080 |
Why?
|
Endodeoxyribonucleases | 1 | 2010 | 164 | 0.080 |
Why?
|
Referral and Consultation | 1 | 2022 | 3600 | 0.080 |
Why?
|
Vasculitis | 1 | 2013 | 521 | 0.080 |
Why?
|
Exodeoxyribonucleases | 1 | 2010 | 192 | 0.080 |
Why?
|
Cell Communication | 1 | 2016 | 1657 | 0.080 |
Why?
|
Binding, Competitive | 1 | 2010 | 1141 | 0.080 |
Why?
|
Pilot Projects | 1 | 2022 | 8631 | 0.080 |
Why?
|
Female | 7 | 2024 | 392644 | 0.070 |
Why?
|
Lymphoma, B-Cell | 1 | 2013 | 940 | 0.070 |
Why?
|
Male | 8 | 2024 | 360804 | 0.070 |
Why?
|
Primary Health Care | 1 | 2022 | 4686 | 0.060 |
Why?
|
Middle Aged | 5 | 2024 | 220895 | 0.060 |
Why?
|
Adult | 5 | 2024 | 221177 | 0.060 |
Why?
|
Hepatitis C, Chronic | 1 | 2013 | 1032 | 0.060 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2013 | 1520 | 0.060 |
Why?
|
Neutrophils | 1 | 2017 | 3767 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8529 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2022 | 20098 | 0.060 |
Why?
|
Severity of Illness Index | 1 | 2022 | 15842 | 0.060 |
Why?
|
DNA Replication | 1 | 2010 | 1418 | 0.050 |
Why?
|
Aging | 1 | 2022 | 8708 | 0.050 |
Why?
|
Propionibacterium acnes | 1 | 2022 | 65 | 0.050 |
Why?
|
Arthritis, Rheumatoid | 1 | 2017 | 3763 | 0.050 |
Why?
|
Cells, Cultured | 1 | 2016 | 18965 | 0.050 |
Why?
|
Young Adult | 2 | 2024 | 59243 | 0.050 |
Why?
|
Swimming | 1 | 2021 | 208 | 0.040 |
Why?
|
Quality of Life | 1 | 2022 | 13367 | 0.040 |
Why?
|
Saccharomyces cerevisiae | 1 | 2010 | 2688 | 0.040 |
Why?
|
Drug Monitoring | 1 | 2024 | 962 | 0.040 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2022 | 1039 | 0.040 |
Why?
|
Adolescent | 4 | 2024 | 88319 | 0.040 |
Why?
|
Histone Acetyltransferases | 1 | 2019 | 336 | 0.030 |
Why?
|
Triglycerides | 1 | 2024 | 2461 | 0.030 |
Why?
|
Acetylation | 1 | 2019 | 1055 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2007 | 384 | 0.030 |
Why?
|
G1 Phase | 1 | 2007 | 403 | 0.030 |
Why?
|
Granulocytes | 1 | 2017 | 551 | 0.030 |
Why?
|
Cholesterol | 1 | 2024 | 2904 | 0.030 |
Why?
|
Methylprednisolone Hemisuccinate | 1 | 2013 | 8 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2019 | 58976 | 0.030 |
Why?
|
United States | 1 | 2022 | 72334 | 0.030 |
Why?
|
Risk Factors | 1 | 2021 | 74206 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2017 | 1596 | 0.030 |
Why?
|
Genes, Tumor Suppressor | 1 | 2007 | 1062 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2019 | 16981 | 0.020 |
Why?
|
Cell Cycle | 1 | 2019 | 2932 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2007 | 1756 | 0.020 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 694 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2007 | 21012 | 0.020 |
Why?
|
Translocation, Genetic | 1 | 2013 | 1393 | 0.020 |
Why?
|
Up-Regulation | 1 | 2007 | 4124 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2007 | 2803 | 0.020 |
Why?
|
Hepacivirus | 1 | 2013 | 1336 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2811 | 0.020 |
Why?
|
Mutation | 1 | 2010 | 30052 | 0.020 |
Why?
|
Animals | 1 | 2016 | 168459 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10445 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 8547 | 0.010 |
Why?
|
Time Factors | 1 | 2024 | 39967 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2013 | 12974 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 29625 | 0.010 |
Why?
|
Signal Transduction | 1 | 2007 | 23445 | 0.010 |
Why?
|
Concepts
(172)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(18)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_